Deals

News Photos

Novartis gets US approval for $2.1 million gene therapy
Click on the image below to view in Stereo 3D

Novartis gets US approval for $2.1 million gene therapy
Swiss pharmaceutical company Novartis on Friday announced it had received US regulatory approval for a gene therapy that treats a rare childhood disorder and has a price tag of $2.1 million, making it the most expensive drug in history. The company said Zolgensma was a one-time treatment for spinal muscular atrophy, a disease that affects about 1 in 10,000 births and which results in death or the need for permanent ventilation by the age of two in 90 percent of cases. Novartis defended the pricing by saying that gene therapy was a transformative new type of treatment and was 50 percent cheaper than current treatments.
More Description
Image URL

 
 
 
vlrPhone
vlrFilter

Project of very low consumption, radiation and bitrate softphones, with the support of the spatial audio, of the frequency shifts and of the ultrasonic communications
Multifunction Audio Filter with Remote Control
More Information
Free the Animation VR
AR

Play to reveal 3D images and 3D models
More Information

WhmSoft Moblog
Copyright (C) 2006-2019 WhmSoft
All Rights Reserved